S&P 500
5,928.25
-0.2%
-12.21
DJI
42,320.59
-0.8%
-356.65
NASDAQ
$19,186.87
+0.2%
+$44.15
Bitcoin
109,562.00
+4.0%
+4,240.73
AAPL
$203.88
-1.4%
-$2.98
AMZN
$203.12
-0.5%
-$0.95
GOOG
$172.57
+4.4%
+$7.25
META
$640.94
+0.6%
+$3.84
MSFT
$456.21
-0.4%
-$1.96
NVDA
$136.94
+1.9%
+$2.56
TSLA
$346.57
+0.8%
+$2.75
180 Life Sciences (NASDAQ: ATNF)
$1.06
(-7.8%)
-$0.09
Price as of May 21, 2025, 10:58 a.m. ET
180 Life Sciences Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
180 Life Sciences Company Info
180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palo Alto, CA.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.